Eppendorf Says it Gets Import Ban on Nanosphere Products in EU, Germany | GenomeWeb

This article has been updated from a previous version to include comments from Nanosphere.

NEW YORK (GenomeWeb News) – Eppendorf said today that it has initiated an import ban against molecular diagnostics workstations and kits sold by Nanosphere because they allegedly infringe patents owned by Eppendorf that relate to microarray-based products.

The import ban covers any and all imports of Northbrook, Ill.-based Nanosphere's Verigene and Verigene SP systems into any country of the European Union, Eppendorf said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.